- GlobeNewswire•yesterdayHarris & Harris Group Portfolio Company, Mersana Therapeutics, Announces FDA Clearance of IND Application for Lead Antibody-Drug Conjugate XMT-1522
NEW YORK, Oct. 24, 2016-- Harris & Harris Group, Inc., an investor in transformative companies enabled by disruptive science, notes the announcement by its portfolio company, Mersana Therapeutics, Inc., ...
- Marketwired•9 days ago
The Long Island Capital Alliance , Long Island's leading non-profit capital formation and business development organization, today announced the successful completion of its Technology Capital Forum held ...
- GlobeNewswire•25 days agoHarris & Harris Group Notes Announcements by Its Portfolio Companies During the Third Quarter of 2016
NEW YORK, Sept. 30, 2016-- Current and prospective shareholders of Harris & Harris Group, Inc. may be interested in a number of announcements by some of our portfolio companies during the third quarter ...
Harris & Harris Group, Inc. (TINY)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Bid||0.10 x 2000|
|Ask||1.89 x 500|
|Day's Range||1.28 - 1.38|
|52wk Range||1.28 - 2.38|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.79|
|Avg Vol (3m)||65,080|
|Dividend & Yield||0.00 (0.00%)|